Pippa Corrie qualified in medicine at Oxford University, having previously undertaken a PhD in anti-cancer drug development. She has been a Consultant Medical Oncologist at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke’s Hospital) since 1997 and is an Associate Lecturer in the University of Cambridge. She has over 25 years of experience leading a regional melanoma clinical service highly integrated with research and been directly involved in development of modern melanoma therapeutics, She previously chaired the NCRI skin cancer group and is a co-founder and Trustee of the UK national charity, Melanoma Focus. Pippa works regionally, nationally and internationally to conduct melanoma clinical and translational trials: she is currently Chief Investigator of the NIHR portfolio MITRE microbiome study and PREMIUM, evaluating neoadjuvant BRAF targeted therapy. She is the NIHR Clinical Research Network National Specialty Lead for Late Phase and International Cancer Trials.